Vol 2017, No 1 (2017)

Table of Contents

Research & Development

Purdue Leverages Exicure’s SNA™ Technology Platform to Diversify its Portfolio Abstract html pdf
Jasmine Kalsi
Pfizer Enriches Oncology Franchise Through BioInvent’s TAM Targeting Antibodies Abstract pdf html
Jasmine Kalsi
Pieris and Servier Collaborate on Immuno-Oncology Drug Development Abstract pdf html
Natasha Piper

Licensing

Akebia and Otsuka partner for vadadustat with a deal worth over US$1 B Abstract pdf html
Jawala Prasad
Novartis Bolsters NASH Pipeline with a Deal with Conatus Abstract html pdf
Subham Nandi

Mergers & Acquisitions

Sumitomo Dainippon Pharma Enriches Oncology Pipeline with Tolero Acquisition Abstract pdf html
Natasha Piper
Takeda Acquires Ariad for US$5.2 B to Add Depth to Oncology Portfolio Abstract pdf html
Subham Nandi & Vipul Sikka


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.